JO

Journal of Hematology & Oncology

First launched in 2008, the Journal of Hematology & Oncology encompasses all aspects of hematology and oncology. It is a peer reviewed, open access journal and the official journal of the Chinese American Hematologist and Oncologist Network (CAHON), publishing high quality articles with rapid turnaround times.

Looking to publish in Journal of Hematology & Oncology? Livewrite integrates seamlessly with Word to help you write, edit, and format faster.

Try Livewrite Now
Subject Hematology, Oncology
Impact Factor 40.4
Quartile Q1
Open Access Type Open
eISSN 1756-8722
Invitation Only Yes
Cost Range £3690.00 GBP / $5190.00 USD / €4490.00 EUR APC

Submission Instructions

Journal of Hematology & Oncology is an invitation-only journal. Submissions are accepted by invitation from the editorial board only. The following article types are accepted:

Research

Cover Letter A cover letter is required. Cover letter must explain why the manuscript should be published in Journal of Hematology & Oncology, address any issues relating to journal policies, declare any potential competing interests, confirm all authors approved submission, and confirm the content has not been published or submitted elsewhere.
Abstract An abstract is required. Abstract must not exceed 350 words. Abstract must be structured. Abstract must include the headings Background, Methods, Results, Conclusions, and Trial registration.
Manuscript Manuscript must include the sections Background, Methods, Results, Discussion, Conclusions, and a Declarations section with all required subheadings. Manuscript must include three to ten keywords, provide a list of abbreviations if abbreviations are used, and document any use of a Large Language Model in the Methods section or another suitable section if Methods is not available.
References References must follow Vancouver style. Only published or in-press articles, clinical trial registration records, abstracts, and publicly available preprints may be cited, unpublished abstracts/data and personal communications must not appear in the reference list, journal abbreviations must follow Index Medicus/MEDLINE, and URLs must be numbered and listed as full references with site title, full URL, and access date.
Figures & Tables Figure titles and legends must be provided in the main manuscript rather than in the graphic file, tables shorter than one page may be placed within the manuscript, and tables longer than one page may be placed at the end of the document. Figures must be numbered in order, multi-panel figures submitted as a single composite file, and tables must be numbered and cited in sequence and created using the word processor's table function rather than embedded as figures.
Reformat to Journal of Hematology & Oncology using Livewrite Premium

Review

Cover Letter A cover letter is required. Cover letter must explain why the manuscript should be published in Journal of Hematology & Oncology, address any issues relating to journal policies, declare any potential competing interests, confirm all authors approved submission, confirm the content has not been published or submitted elsewhere, and name the special issue if applicable.
Abstract An abstract is required. Abstract must not exceed 350 words. Abstract must be structured. Abstract must include Background, main body of the abstract, and short conclusion.
Manuscript Manuscript must include a title page, Background, Main text, Conclusions, and a Declarations section with the required subheadings. Review manuscripts must include three to ten keywords and a Declarations section containing Ethics approval and consent to participate, Consent for publication, Availability of data and materials, Competing interests, Funding, Authors' contributions, Acknowledgements, and optional Authors' information, with 'Not applicable' used for any irrelevant section, and any Large Language Model use must be documented in the Methods section or another suitable part of the manuscript.
References References must follow Vancouver style. Only published or in-press articles, clinical trial registration records, abstracts, and public preprints may be cited, unpublished abstracts, unpublished data, and personal communications must be excluded from the reference list, journal abbreviations must follow Index Medicus/MEDLINE, and web links must appear as numbered references with full site title, URL, and access date.
Figures & Tables Tables shorter than one page may be placed within the manuscript, tables longer than one page may be placed at the end of the text file with their intended location indicated, and figure titles and legends must be provided in the main manuscript rather than in the graphic file. Figures and tables must be numbered in the order cited, multi-panel figures submitted as a single composite file, tables created using the word processor's table function rather than as figures or spreadsheet files, and table footnotes indicated by superscript lower-case letters or asterisks for significance values.
Reformat to Journal of Hematology & Oncology using Livewrite Premium

Correspondence

Cover Letter Cover letter is required. Cover letter must explain why the manuscript should be published, address any journal policy issues, declare any potential competing interests, confirm all authors approved submission, confirm the content has not been published or submitted elsewhere, and name the special issue if applicable.
Abstract Abstract is required. Abstract must not exceed 250 words. Abstract must be unstructured and presented as one paragraph.
Manuscript Main text must not exceed 700 words. Main text must start with "To the editor" and manuscripts must include a Declarations section with the specified subheadings, using "Not applicable" where a heading is not relevant. Manuscripts must include three to ten keywords and a list of abbreviations if abbreviations are used in the text.
References References must not exceed 12. References must follow Vancouver style. Web links and URLs must be cited with a reference number and included in the reference list in full with the site title, URL, and access date.
Figures & Tables Correspondence may include a maximum of two figures, or two tables, or one figure plus one table. Tables shorter than one page may be placed within the manuscript, while longer tables may be placed at the end of the document with their intended location indicated in the text. Figure titles and legends must be provided in the main manuscript rather than in the graphic file.
Reformat to Journal of Hematology & Oncology using Livewrite Premium

Case Report

Cover Letter Cover letter is required. Cover letter must explain why the manuscript should be published, address any issues relating to journal policies, declare any potential competing interests, confirm all authors approved submission, and confirm the manuscript has not been published or submitted elsewhere.
Abstract Abstract is required. Abstract must not exceed 350 words. Abstract must be structured. Abstract must include the headings Background, Case presentation, and Conclusions.
Manuscript Manuscript must include the sections Background, Case presentation, Discussion and Conclusions, and a Declarations section. Manuscript must include three to ten keywords, a Declarations section with the subheadings Ethics approval and consent to participate, Consent for publication, Availability of data and materials, Competing interests, Funding, Authors' contributions, and Acknowledgements, use 'Not applicable' for any irrelevant Declarations subheading, and document any use of a Large Language Model in the manuscript.
References References must follow Vancouver style. Web links and URLs must be cited by reference number and included in the reference list in full with the site title, URL, and access date, and unpublished abstracts, unpublished data, and personal communications must not be included in the reference list.
Figures & Tables Tables shorter than one page may be placed within the manuscript, tables longer than one page may be placed at the end of the document, and figure titles and legends must be provided in the main manuscript rather than in the graphic file. Figures must be numbered in order of first mention and multi-panel figures submitted as a single composite file, while tables must be numbered and cited sequentially, created with the word processor table function, and not embedded as figures.
Reformat to Journal of Hematology & Oncology using Livewrite Premium

Research Highlight

Cover Letter A cover letter is required. Cover letter must explain why the manuscript should be published in Journal of Hematology & Oncology, address any issues relating to journal policies, declare any potential competing interests, confirm all authors approved the submission, confirm the content has not been published or submitted elsewhere, and name the special issue if applicable.
Abstract An abstract is required. Abstract must not exceed 250 words. Abstract structure is not explicitly specified. Abstract must briefly summarize the aim, findings, or purpose of the article.
Manuscript Research Highlights must provide a balanced overview of the field, must not focus on the authors' own work or that of close colleagues, must not include original data or analysis, and are usually based on one or more recently published research articles placed in the context of the current literature. Manuscript must include three to ten keywords, a Declarations section with the specified subheadings and 'Not applicable' where relevant, a list of abbreviations if abbreviations are used, and documentation of any Large Language Model use in the Methods section or a suitable alternative section.
References References must follow Vancouver style. Only published, in-press, or publicly available preprint articles, clinical trial registration records, and abstracts may be cited; unpublished abstracts, unpublished data, and personal communications must not appear in the reference list; journal abbreviations must follow Index Medicus/MEDLINE; and web links or dataset identifiers must be included in the reference list as full URLs with required site details and access date where applicable.
Figures & Tables Tables shorter than one page may be placed within the manuscript, tables longer than one page may be placed at the end of the text file with intended locations indicated in the text, and figure titles and legends must appear in the main manuscript rather than in the graphic files. Figures must be numbered in text order and submitted as correctly oriented single composite files for multi-panel figures, while tables must be numbered and cited in sequence, created using the word processor's table object rather than embedded as figures or spreadsheets, and footnotes must use superscript lower-case letters or asterisks where applicable.
Reformat to Journal of Hematology & Oncology using Livewrite Premium

Recent Publications

Circulating tumor DNA in breast cancer: updates from SABCS 2025

Iris Zhi, Xianghui Zou, Min Sun, Nancy Chan, Naomi Ko, Neil Vasan, Shridar Ganesan, Cynthia Ma

10.1186/s13045-026-01808-4
View Publication

A first-in-class bifunctional antibody targeting CD20 and CD37 remodels the immune microenvironment in relapsed or refractory B-cell malignancies

Li Wang, Jiaying Liu, Keshu Zhou, Zengjun Li, Yun Zeng, Ying Qian, Yuping Sun, Hui Wu, Lindsay Roerker, Peter Tan, Chen Ma, Liwei Zhou, Xianlin Duan, Xiaoyan Kang, Weili Zhao

10.1186/s13045-026-01796-5
View Publication

Cardiovascular adverse events associated with bispecific antibodies in relapsed or refractory B-cell non-Hodgkin lymphomas

Malak Munir, Ahmed Sayed, Dae Hyun Lee, Farrukh Awan, Sanam Ghazi, Jean Kim, Daniel Addison, Narendranath Epperla

10.1186/s13045-026-01809-3
View Publication

Standard-of-care ciltacabtagene autoleucel in earlier versus later lines of therapy for relapsed or refractory multiple myeloma: a nationwide registry analysis

Nico Gagelmann, Hermann Einsele, Sarah Flossdorf, Samih Smaili, Klaus Metzeler, Christoph Scheid, Lars Bullinger, Sandra Sauer, Marc Raab, Justus Duyster, Hans Christian Reinhardt, Raphael Teipel, Winfried Alsdorf, Claudia Lengerke, Wolfgang Herr, Natalie Schub, Francis Ayuketang Ayuk, Florian Bassermann, Christian Schultze-Florey, Roland Schroers, Mathias Hänel, Nicola Giesen, Ahmet Elmaagacli, Andreas Burchert, Thomas Weber, Dimitrios Mougiakakos, Stefan Knop, Fabian Müller, Nicolaus Kröger, Maximilian Merz

10.1186/s13045-026-01806-6
View Publication

CD20-directed antibody-drug conjugates in non-hodgkin lymphoma: translating preclinical promise into clinical reality

Leila Omidvar, Ali Hussein Mer, Yousef Mirzaei, Mohammad-Reza Sanaye-Pasand, Saeed Jahandideh, Mahmoud Hassani, Meghdad Abdollahpour-Alitappeh

10.1186/s13045-026-01807-5
View Publication

Frequently asked questions

How long does it take to publish?

Submission to first decision (median): 8 days.

Reformat to Journal of Hematology & Oncology using Livewrite Premium

Is a cover letter required?

A cover letter is required. It should explain why the manuscript should be published in Journal of Hematology & Oncology, address any issues relating to journal policies, declare potential competing interests, confirm that all authors approved the submission, confirm the manuscript has not been published or submitted elsewhere, and name the special issue if applicable. Authors may also suggest preferred or non-preferred peer reviewers in the cover letter.

Reformat to Journal of Hematology & Oncology using Livewrite Premium

What are the publication costs?

Research Topics

CAR-T cell therapy research Acute Myeloid Leukemia Research Lymphoma Diagnosis and Treatment Immune Cell Function and Interaction Cancer Immunotherapy and Biomarkers Chronic Lymphocytic Leukemia Research Multiple Myeloma Research and Treatments Cancer-related molecular mechanisms research Acute Lymphoblastic Leukemia research Hematopoietic Stem Cell Transplantation RNA modifications and cancer Immunotherapy and Immune Responses Protein Degradation and Inhibitors MicroRNA in disease regulation Chronic Myeloid Leukemia Treatments Cancer Genomics and Diagnostics Epigenetics and DNA Methylation Immune cells in cancer Lung Cancer Treatments and Mutations Myeloproliferative Neoplasms: Diagnosis and Treatment Circular RNAs in diseases Virus-based gene therapy research Histone Deacetylase Inhibitors Research Peptidase Inhibition and Analysis Monoclonal and Polyclonal Antibodies Research

Related Journals

On
OncoImmunology Landes Bioscience
TL
The Lancet Haematology Elsevier BV
CA
CA A Cancer Journal for Clinicians WILEY
CO
Current Oncology Reports Springer Science+Business Media
JG
JCO Global Oncology LIPPINCOTT WILLIAMS & WILKINS
ID
Infectious Diseases of Poverty BioMed Central